Relation of weight maintenance and dietary restraint to peroxisome proliferator-activated receptor γ2, glucocorticoid receptor, and ciliary neurotrophic factor polymorphisms

American Journal of Clinical Nutrition

Volumn 82, Issue 4, 2005, Pages 740-746

  Vogels, Neeltje ^a   Mariman, Edwin C M ^a   Bouwman, Freek G ^a   Kester, Arnold D M ^a   Diepvens, Kristel ^a   Westerterp Plantenga, Margriet S ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Body weight loss; Dietary restraint; Glucocorticoid receptor; GRl; Obesity; Peroxisome proliferator activated receptor 2; PPAR 2; Weight maintenance

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLUCOCORTICOID RECEPTOR; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; DNA POLYMORPHISM; FEEDING BEHAVIOR; GENOTYPE; HEREDITY; HUMAN; HUMAN EXPERIMENT; HUNGER; PHYSICAL ACTIVITY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; WAIST CIRCUMFERENCE; WEIGHT CONTROL; WEIGHT REDUCTION; ATTITUDE TO HEALTH; BLOOD; CALORIC RESTRICTION; DIET THERAPY; EATING; EXERCISE; FEMALE; GENETIC POLYMORPHISM; GENETICS; LONGITUDINAL STUDY; LOW CALORY DIET; MALE; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; PHYSIOLOGY;

ADULT; AGED; ATTITUDE TO HEALTH; BODY COMPOSITION; CALORIC RESTRICTION; CILIARY NEUROTROPHIC FACTOR; DIET, REDUCING; EATING; EXERCISE; FEMALE; GENOTYPE; HUMANS; HUNGER; LEPTIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; POLYMORPHISM, GENETIC; PPAR GAMMA; QUESTIONNAIRES; RECEPTORS, GLUCOCORTICOID; WEIGHT LOSS;

EID: 27744455929     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/82.4.740     Document Type: Article

References (45)

1. Pasman WJ, Rossner S, Westerterp-Plantenga MS, Saris WH. Body weight changes after treatment of obesity or pregnancy. Milan, Italy: Edra, 1999.
2. Westerterp-Plantenga MS, Kempen KP, Saris WH. Determinants of weight maintenance in women after diet-induced weight reduction. Int J Obes Relat Metah Disord 1998;22:1-6.
3. Pasman WJ. Saris WH. Westerterp-Plantenga MS. Predictors of weight maintenance. Obes Res 1999;7:43-50.
4. Anderson JW, Vichitbandra S. Qian W, Kryscio RJ. Long-term weight maintenance after an intensive weight-loss program. J Am Coll Nutr 1999;18:620-7.
5. Leermakers EA, Perri MG. Shigaki CL, Fuller PR. Effects of exercise-focused versus weight-focused maintenance programs on the management of obesity. Addict Behav 1999;24:219-27.
6. Ewbank PP, Darga LL, Lucas CP. Physical activity as a predictor of weight maintenance in previously obese subjects. Obes Res 1995;3:257-63.
7. Vogels N, Westerterp-Plantenga MS. Categorical strategies based on subject characteristics of dietary restraint and physical activity, for weight maintenance. Int J Obes Relat Metab Disord 2005;29:849-57.
8. Tremblay A, Bouchard L, Bouchard C, Despres JP, Drapeau V, Perusse L. Long-term adiposity changes are related to a glucocorticoid receptor polymorphism in young females. J Clin Endocrinol Metab 2003;88:3141-5.
9. Rosmond R, Chagnon M, Bouchard C. The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes Metab Res Rev 2003;19:159-63.
10. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR. Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro 12A1a) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001;50:2172-6.
11. Ukkola O, Rosmond R, Tremblay A, Bouchard C. Glucocorticoid receptor Bcl I variant is associated with an increased atherogenic profile in response to long-term overfeeding. Atherosclerosis 2001;157:221-4.
12. van Rossum EF, Koper JW, van den Beld AW, et al. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin Endocrinol (Oxf) 2003;59:585-92.
13. Rosmond R, Chagnon YC, Holm G, et al. A glucocorticoid receptor gene markeris associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res 2000;8:211-8.
14. Buemann B, Vohl MC, Chagnon M, et al. Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res 1997;5:186-92.
15. Munzberg H, Tafel J, Busing B, et al. Screening for variability in the ciliary neurotrophic factor (CNTF) gene: no evidence for association with human obesity. Exp Clin Endocrinol Diabetes 1998;106:108-12.
16. Takahashi R, Yokoji H, Misawa H, Hayashi M, Hu J, Deguchi T. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat Genet 1994;7:79-84.
17. O' Dell SD, Syddall HE, Sayer AA, et al. Null mutation in human ciliary neurotrophic factor gene confers higher body mass index in males. Eur J Hum Genet 2002;10:749-52.
18. Jacob AC, Zmuda JM, Cauley JA, et al. Ciliary neurotrophic factor (CNTF) genotype and body composition. Eur J Hum Genet 2004;12:372-6.
19. van Marken Lichtenbelt WD, Westerterp KR, Wouters L. Deuterium dilution as a method for determining total body water: effect of test protocol and sampling time. Br J Nutr 1994;72:491-7.
20. Schoeller DA, van Santen E, Peterson DW, Dietz W, Jaspan J, Klein PD. Total body water measurement in humans with 18O and 2H labeled water. Am J Clin Nutr 1980;33:2686-93.
21. Westerterp KR, Wouters L, van Marken Lichtenbelt WD. The Maastricht protocol for the measurement of body composition and energy expenditure with labeled water. Obes Res 1995;3(suppl):49-57.
22. Stunkard AJ, Messick S. The Three-Factor Eating Questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985;29:71-83.
23. Westerterp-Plantenga MS, Rolland V, Wilson SA, Westerterp KR. Satiety related to 24 h diet-induced thermogenesis during high protein/ carbohydrate vs high fat diets measured in a respiration chamber. Eur J Clin Nutr 1999;53:495-502.
24. Laessle RG, Tuschl RJ, Kotthaus BC, Pirke KM. A comparison of the validity of three scales for the assessment of dietary restraint. J Abnorm Psychol 1989;98:504-7.
25. Neale BM, Mazzeo SE, Bulik CM. A twin study of dietary restraint, disinhibition and hunger: an examination of the eating inventory (three factor eating questionnaire). Twin Res 2003;6:471-8.
26. Laessle RG, Tuschl RJ, Kotthaus BC, Pirke KM. Behavioral and biological correlates of dietary restraint in normal life. Appetite 1989;12:83-94.
27. Tuschl RJ, Platte P, Laessle RG, Stichler W, Pirke KM. Energy expenditure and everyday eating behavior in healthy young women. Am J Clin Nutr 1990;52:81-6.
28. Philippaerts RM, Westerterp KR, Lefevre J. Doubly labelled water validation of three physical activity questionnaires. Int J Sports Med 1999; 20:284-9.
29. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-42.
30. Yen CJ, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997;241:270-4.
31. Weinsier RL, Hunter GR, Desmond RA, Byrne NM, Zuckerman PA, Darnell BE. Free-living activity energy expenditure in women successful and unsuccessful at maintaining a normal body weight. Am J Clin Nutr 2002;75:499-504.
32. Sartorio A, Agosti F, Resnik M, Lafortuna CL. Effects of a 3-week integrated body weight reduction program on leptin levels and body composition in severe obese subjects. J Endocrinol Invest 2003;26:250-6.
33. Nagy TR, Davies SL, Hunter GR, Darnell B, Weinsier RL. Serum leptin concentrations and weight gain in postobese, postmenopausal women. Obes Res 1998;6:257-61.
34. Neuhauser-Berthold M, Herbert BM, Luhrmann PM, et al. Resting metabolic rate, body composition, and serum leptin concentrations in a free-living elderly population. Eur J Endocrinol 2000;142:486-92.
35. Sudi KM, Gallistl S, Borkenstein MH, et al. Effects of weight loss on leptin, sex hormones, and measures of adiposity in obese children. Endocrine 2001;14:429-35.
36. Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc 2000; 59:359-71.
37. Lejeune MP, Van Aggel-Leijssen DP, Van Baak MA, Westerterp-Plantenga MS. Effects of dietary restraint vs exercise during weight maintenance in obese men. Eur J Clin Nutr 2003;57:1338-44.
38. McGuire MT, Jeffery RW, French SA, Hannan PJ. The relationship between restraint and weight and weight-related behaviors among individuals in a community weight gain prevention trial. Int J Obes Relat Metab Disord 2001;25:574-80.
39. Dykes J, Brunner EJ, Martikainen PT, Wardle J. Socioeconomic gradient in body size and obesity among women: the role of dietary restraint, disinhibition and hunger in the Whitehall II study. Int J Obes Relat Metab Disord 2004;28:262-8.
40. Hays NP, et al. Eating behavior correlates of adult weight gain and obesity in healthy women aged 55-65 y. Am J Clin Nutr 2002;75:476-83.
41. Williamson DA, Lawson OJ, Brooks ER, et al. Association of body mass with dietary restraint and disinhibition. Appetite 1995;25:31-41.
42. Lawson OJ, Williamson DA, Champagne CM, et al. The association of body weight, dietary intake, and energy expenditure with dietary restraint and disinhibition. Obes Res 1995;3:153-61.
43. McGuire MT, Wing RR, Klem ML, Lang W, Hill JO. What predicts weight regain in a group of successful weight losers? J Consult Clin Psychol 1999;67:177-85.
44. Douglas JA, Erdos MR, Watanabe RM, et al. The peroxisome proliferator-activated receptor-gamma2 Pro1Ala variant: association with type 2 diabetes and trait differences. Diabetes 2001;50:886-90.
45. Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MI. Effect of the Pro 12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia 2001;44:925-6.